Am J Perinatol 2004; 21(8): 455-462
DOI: 10.1055/s-2004-835962
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Homeostatic Model Assessment and Risk for Hypertension During Pregnancy: A Longitudinal Prospective Study

Gustavo Romero-Gutiérrez1 , Juan Manuel Malacara2 , Norma Amador1 , César Fierro-Martínez1 , Luis Manuel Muñoz-Guevara1 , Roberto Molina-Rodríguez1
  • 1Unit of Clinical Epidemiological Research, Department of Obstetrics and Gynecology, Mexican Institute of Social Security, Leon, Mexico
  • 2Institute of Research in Medicine, University of Guanajuato, Guanajuato, Mexico
Further Information

Publication History

Publication Date:
06 December 2004 (online)

ABSTRACT

The propose of this study was to determine the association between insulin resistance and hypertension during pregnancy with the homeostatic model assessment (HOMA-IR). A longitudinal prospective study was carried out. One hundred sixty normotensive pregnant women were followed from the first trimester until delivery. HOMA-IR levels were determined each trimester. Statistical analysis included one-way analysis of variance and multivariate logistic regression. At follow-up, 134 women (83.8%) remained normotensive, 18 (11.2%) developed gestational hypertension, and 8 (5%) developed preeclampsia. At first trimester, HOMA-IR levels were higher in women who developed gestational hypertension (2.1 ± 0.2) than in women who developed preeclampsia (1.2 ± 0.0), or remained normotensive (1.2 ± 0.3); p < 0.01. In the logistic regression analysis, HOMA-IR levels at first trimester were statistically significant (p = 0.03) to predict development of gestational hypertension. Our results support the use of the HOMA-IR as an alternative index for the assessment of the risk for hypertension during pregnancy.

REFERENCES

  • 1 Leitch C R, Cameron A D, Walker J J. The changing pattern of eclampsia over a 60-year period.  Br J Obstet Gynaecol. 1997;  104 917-922
  • 2 Pridjian G. Preeclampsia. Part 2: experimental and genetic considerations.  Obstet Gynecol Surv. 2002;  57 619-640
  • 3 O'Hare J A. The enigma of insulin resistance and hypertension. Insulin resistance, blood pressure and the circulation.  Am J Med. 1988;  84 505-510
  • 4 Cotton D B, Standley P R, Kruger M, Mason B A, Sowers J R. Insulin resistance and ponderosity in women developing hypertension in pregnancy.  Am J Obstet Gynecol. 1995;  172 386
  • 5 Wolf M, Sandler L, Muñoz K, Hsu K, Ecker J L. Thadhani R. First trimester insulin resistance and subsequent preeclampsia: a prospective study.  J Clin Endocrinol Metab. 2002;  87 1563-1568
  • 6 Wolf M, Sandler L, Jimenez-Kimble R, Shah A, Ecker J, Thadhani R. Insulin resistance but not inflammation is associated with gestational hypertension.  Hypertension. 2002;  40 886-891
  • 7 Bonora E, Targher G, Alberiche M et al.. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.  Diabetes Care. 2000;  23 57-63
  • 8 Solomon C G, Seely E W. Hypertension in pregnancy: a manifestation of the insulin resistance syndrome?.  Hypertension. 2001;  37 232-239
  • 9 National high blood pressure education program working group on high blood pressure in pregnancy.  Am J Obstet Gynecol. 2000;  183 S1-S22
  • 10 Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
  • 11 Altman D G. Practical Statistics for Medical Research. London; Chapman & Hall 1991: 351
  • 12 Caritis S, Sibai B, Hauth J et al.. Predictors of pre-eclampsia in women at high risk.  Am J Obstet Gynecol. 1998;  179 946-951
  • 13 Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia.  JAMA. 1991;  266 237-241
  • 14 Ram C VS. Antihypertensive drugs: an overview.  Am J Cardiovasc Drugs. 2002;  2 77-89
  • 15 Quinlan R W, Cruz A C, Buhi W C, Martin M. Changes in placental ultrasonic appearance. II. Pathologic significance of grade III placental changes.  Am J Obstet Gynecol. 1982;  144 471-473
  • 16 Ryan E A, Enns L. Role of gestational hormones in the induction of insulin resistance.  J Clin Endocrinol Metab. 1988;  67 341-347
  • 17 Stanley K, Fraser R, Bruce C. Physiological changes in insulin resistance in human pregnancy: longitudinal study with the hyperinsulinaemic euglycaemic clamp technique.  Br J Obstet Gynaecol. 1998;  105 756-759
  • 18 Bartha J L, Romero-Carmona R, Torrejon-Cardoso R, Comino-Delgado R. Insulin, insulin-like growth factor-1, and insulin resistance in women with pregnancy-induced hypertension.  Am J Obstet Gynecol. 2002;  187 735-740
  • 19 Sharman A, Haldiya S S. Insulin sensitivity in pre-eclampsia.  J Assoc Physicians India. 2002;  50 1022-1027
  • 20 Seely E W, Solomon C G. Insulin resistance and its potential role in pregnancy-induced hypertension.  J Clin Endocrinol Metab. 2003;  88 2393-2398

Gustavo Romero-GutiérrezM.D. Ph.D. 

Unidad de Investigación en Epidemiología Clínica, Hospital de Gineco-Pediatría #48

Piso 5, Instituto Mexicano del Seguro Social, Fuego 216 Col. Jardines del Moral

C. P. 37160 León, Guanajuato, México

    >